TL;DR: UnitedHealthcare modified its clinical diagnostic laboratory services coverage policy for Medicare Advantage, effective February 2, 2026. Here's what billing teams need to do.
UnitedHealthcare updated its Medicare Advantage medical policy for clinical diagnostic laboratory services under policy code clinical-diagnostic-laboratory-services. The revision reinforces the distinction between screening and diagnostic testing, reaffirms CLIA compliance requirements, and aligns coverage determinations with CMS National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). This policy does not list specific CPT or HCPCS codes — your reimbursement exposure depends on whether your lab orders are coded as screening or diagnostic, and whether the underlying NCD or LCD supports coverage.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | UnitedHealthcare |
| Policy | Clinical Diagnostic Laboratory Services – Medicare Advantage Medical Policy |
| Policy Code | clinical-diagnostic-laboratory-services |
| Change Type | Modified |
| Effective Date | February 2, 2026 |
| Impact Level | High |
| Specialties Affected | Laboratories, primary care, oncology, infectious disease, OB/GYN, urology, gastroenterology, endocrinology |
| Key Action | Audit all lab orders to confirm screening vs. diagnostic coding aligns with the ordering diagnosis — before submitting claims dated on or after February 2, 2026 |
UnitedHealthcare Clinical Diagnostic Laboratory Coverage Criteria and Medical Necessity Requirements 2026
The UHC clinical diagnostic laboratory services coverage policy draws a hard line between screening and diagnostic testing. That line determines whether a claim pays or denies. Get it wrong, and you're looking at a claim denial — no matter how medically appropriate the test was.
Screening tests are performed when no sign, symptom, or confirmed diagnosis exists. The member hasn't been exposed to the disease, and the test is being run to catch something early. Diagnostic tests are ordered because a sign or symptom is already present. The ICD-10-CM diagnosis code you attach to the claim tells UnitedHealthcare which category applies.
This is not a new concept — but the policy update as of February 2, 2026 makes clear that UnitedHealthcare will enforce this distinction under Medicare Advantage the same way traditional Medicare does. If your team bills diagnostic lab services with screening diagnoses, or vice versa, expect denials.
Medical Necessity Under This Coverage Policy
Medical necessity for clinical diagnostic laboratory services requires that the test be ordered by a treating physician or qualified nonphysician practitioner under 42 CFR 410.32(a). Ordered doesn't just mean requested. The policy means the ordering provider must be treating the member for the condition that justifies the test.
Standing orders or blanket lab panels are a risk area here. If a test is ordered as part of a routine workflow but not tied to an active treatment relationship and a current medical need, UnitedHealthcare can deny it as not medically necessary under Section 1862(a)(1)(A) of the Act.
The policy also requires that lab services be "used promptly." This matters for your revenue cycle. Labs drawn on one date and not used in the course of treatment may face scrutiny. Document the clinical rationale in the ordering encounter — and make sure the ordering provider's documentation supports the ICD-10 you submit.
Prior Authorization and NCD/LCD Compliance
The policy does not specify a blanket prior authorization requirement for clinical diagnostic laboratory services. However, prior authorization requirements can apply at the plan level for specific tests — particularly molecular and genomic testing, advanced panels, or tests governed by a specific NCD.
Your billing team should check the applicable NCD or LCD before submitting claims for any non-routine lab service. This policy explicitly requires compliance with all applicable NCDs and LCDs where they exist. Compliance isn't optional, and UnitedHealthcare flags it as a condition of payment — not a courtesy.
Medicare Administrative Contractors (MACs) issue Local Coverage Determinations that govern coverage in specific jurisdictions. If your lab serves members across multiple MAC jurisdictions, the LCD that applies depends on where the member's Medicare benefit is administered — not where your lab is located. That's a common billing mistake, and it causes denials.
UnitedHealthcare Clinical Diagnostic Laboratory Exclusions and Non-Covered Indications
The policy references "Nationally Non-Covered Indications" — a category UnitedHealthcare uses to deny services that CMS has determined do not meet the reasonable and necessary standard under Section 1862(a)(1)(A).
The full list of non-covered indications in the underlying CMS guidance is extensive. The policy's reference to this category means UnitedHealthcare will apply CMS non-coverage rules directly to Medicare Advantage claims. If CMS has nationally excluded a test or indication, UHC will deny it the same way.
The highest-risk area for your billing team: tests that are covered as screening under specific NCD criteria but billed with a diagnostic code — or vice versa. Both directions create denials. Screening services billed with a diagnostic ICD-10 can trigger a medical necessity review. Diagnostic services billed with a screening code often hit a frequency or eligibility limitation they don't actually face.
Title XVI services also appear in the policy's non-coverage framework. This is a narrower category relevant to Supplemental Security Income-related coverage, but flag it for your compliance officer if your Medicare Advantage population includes dual-eligible members.
Coverage Indications at a Glance
| Indication | Status | Relevant NCD | Notes |
|---|---|---|---|
| Prostate cancer screening (PSA) | Covered (screening) | NCD 210.1 | Frequency and eligibility criteria apply; see Medicare Preventive Services Chart |
| Cervical cancer screening with HPV testing | Covered (screening) | NCD 210.2.1 | Age and frequency limits apply |
| Pap test screening | Covered (screening) | NCD 210.2 | Frequency-limited; eligibility criteria in NCD |
| Colorectal cancer screening tests | Covered (screening) | NCD 210.3 | Multiple modalities covered; see NCD for code-level criteria |
| Cardiovascular disease screening tests | Covered (screening) | See Medicare Preventive Services Chart | Coding criteria sourced from Preventive Services Chart |
| Diabetes screening | Covered (screening) | See Medicare Preventive Services Chart | Risk-factor eligibility required |
| Hepatitis B virus (HBV) infection screening | Covered (screening) | NCD 210.6 | High-risk criteria apply |
| HIV screening | Covered (screening) | NCD 210.7 | Frequency and risk criteria apply |
| Hepatitis C virus (HCV) screening in adults | Covered (screening) | NCD 210.13 | Age and risk criteria; see NCD |
| STI screening and HIBC counseling | Covered (screening) | NCD 210.10 | High-intensity behavioral counseling component has separate billing guidelines |
| Diagnostic lab testing (sign/symptom present) | Covered (diagnostic) | LCD/NCD dependent | Must use sign/symptom ICD-10; ordering provider must be treating provider |
| Lab services not ordered by treating provider | Not Covered | N/A | 42 CFR 410.32(a) — must be ordered as part of active treatment relationship |
| Nationally non-covered indications per CMS | Not Covered | CMS NCD framework | UHC applies CMS non-coverage determinations directly to MA claims |
UnitedHealthcare Clinical Diagnostic Laboratory Billing Guidelines and Action Items 2026
These are the specific steps your team should take before and after the February 2, 2026 effective date.
| # | Action Item |
|---|---|
| 1 | Audit your ICD-10 coding for all lab claims. Before submitting any clinical lab claim dated on or after February 2, 2026, confirm whether the test is screening or diagnostic. The ICD-10 code you submit must match the clinical context. A diagnostic code on a screening test — or a screening code on a diagnostic test — is a denial waiting to happen. |
| 2 | Verify ordering provider compliance with 42 CFR 410.32(a). The ordering provider must be treating the member. Pull a sample of recent lab orders and confirm that every order ties to an active treatment relationship. If your lab processes orders from referring providers who aren't the treating physician, flag those for review. |
| 3 | Cross-reference applicable NCDs for all preventive lab billing. For the 10 NCD-covered screening services listed in this policy (NCD 210.1 through NCD 210.13), pull the specific coding criteria from the Medicare Coverage Database before billing. Frequency limits, eligibility requirements, and diagnosis code requirements vary by NCD. One wrong code on a PSA or HCV screen kills the claim. |
| 4 | Identify your MAC jurisdiction for each Medicare Advantage member. Local Coverage Determinations apply at the MAC level. If you bill for members in multiple jurisdictions, your clinical diagnostic laboratory billing team needs to know which LCD governs each claim. The MAC for the member's benefit — not your lab's location — controls LCD applicability. Build this into your workflow before the effective date. |
| 5 | Check plan-level prior authorization requirements for non-routine tests. This policy doesn't mandate blanket prior authorization for lab services, but individual UnitedHealthcare Medicare Advantage plans can add PA requirements on top of the base policy — especially for molecular diagnostics, genomic panels, and specialty testing. Pull the specific plan's benefit documentation for any high-cost or high-complexity lab order. |
| 6 | Document medical necessity at the point of order. The ordering provider's encounter note must support the ICD-10 code submitted on the lab claim. "Used promptly" in the policy language means the test must connect to active clinical management — not be filed away. Make sure your documentation standards require that connection before the order is finalized. |
| 7 | Talk to your compliance officer if your team bills dual-eligible members. The policy's reference to Title XVI non-coverage adds a layer of complexity for members who are both Medicare and Medicaid eligible. If your Medicare Advantage population includes duals, confirm how UHC applies this provision before you submit claims for that segment. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Clinical Diagnostic Laboratory Services Under clinical-diagnostic-laboratory-services
This policy does not list specific CPT, HCPCS, or ICD-10 codes. UnitedHealthcare's coverage determinations for clinical diagnostic laboratory services are governed at the NCD and LCD level — meaning the specific codes that apply depend on which NCD or LCD covers the test in question.
For code-level billing guidance, pull the applicable NCD from the CMS Coverage Database or the relevant LCD from your MAC. The NCDs referenced directly in this policy are:
| NCD Number | Covered Service |
|---|---|
| NCD 210.1 | Prostate Cancer Screening Tests |
| NCD 210.2 | Pap Tests Screening |
| NCD 210.2.1 | Cervical Cancer Screening with HPV Tests |
| NCD 210.3 | Colorectal Cancer Screening Tests |
| NCD 210.6 | Screening for Hepatitis B Virus (HBV) Infection |
| NCD 210.7 | Human Immunodeficiency Virus (HIV) Screening |
| NCD 210.10 | Sexually Transmitted Infection (STI) & High Intensity Behavioral Counseling (HIBC) |
| NCD 210.13 | Screening for Hepatitis C Virus (HCV) in Adults |
Each NCD has its own CPT and HCPCS code list, diagnosis code requirements, and frequency limits. The Medicare Preventive Services Chart — referenced throughout this policy — is the fastest lookup for coding criteria on preventive lab services. Use it.
Do not bill clinical diagnostic laboratory services under this policy using internally constructed code lists. Go to the NCD or LCD directly. That's where UnitedHealthcare will validate your claim.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.